S. 373Senate112th Congress (2011-2013)In Committee

Fair Prescription Drug Competition Act

Introduced February 16, 2011

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

February 16, 2011

View full timeline
SenateIntro Referral

Introduced in Senate

February 16, 2011

SenateIntro Referral

Sponsor introductory remarks on measure. (CR S797)

February 16, 2011

SenateIntro Referral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

February 16, 2011

Floor Debate

4 members

What members said about S. 373 on the floor

2 Republicans2 Democrats
Susan M. Collins
Sen. Susan M. CollinsR-ME · Feb 16, 2011

Mr. President, Americans are resilient. Throughout our Nation's history, we have stood up to every challenge and we have stood together. At this moment in history, we face the challenge of recovering…

John D. Rockefeller IV
Sen. John D. Rockefeller IVD-WV · Feb 16, 2011

Mr. President, I rise today with my colleagues, Senators Shaheen, Leahy, Inouye, Stabenow, and Schumer, to reintroduce an important piece of legislation, the Fair Prescription Drug Competition Act.…

John D. Rockefeller IV
Sen. John D. Rockefeller IVD-WV · Feb 16, 2011

Mr. President, I rise today with my colleagues, Senators Shaheen, Leahy, Inouye, Stabenow, and Schumer, to reintroduce an important piece of legislation, the Fair Prescription Drug Competition Act.…

Benjamin L. Cardin
Sen. Benjamin L. CardinD-MD · Feb 16, 2011

Mr. President, the Internet has had a profound impact on the daily lives of millions of Americans by enhancing communications, commerce, education and socialization between and among persons…

James M. Inhofe
Sen. James M. InhofeR-OK · Feb 16, 2011

Mr. President, we are trying to resolve one of the great problems I am sure my colleagues are sensitive to; that is, the infrastructure of this country. Today we have two witnesses next to each…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued February 16, 2011

II

112th CONGRESS

1st Session

S. 373

IN THE SENATE OF THE UNITED STATES

February 16, 2011

Mr. Rockefeller (for himself, Mrs. Shaheen, Mr. Leahy, Mr. Inouye, Ms. Stabenow, and Mr. Schumer) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.

1.

Short title

This Act may be cited as the Fair Prescription Drug Competition Act.

2.

Prohibition of authorized generics

(a)

In general

Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended by adding at the end the following:

(w)

Prohibition of authorized generic drugs

(1)

In general

Notwithstanding any other provision of this Act, no holder of a new drug application approved under subsection (c) shall manufacture, market, sell, or distribute an authorized generic drug, directly or indirectly, or authorize any other person to manufacture, market, sell, or distribute an authorized generic drug.

(2)

Authorized generic drug

For purposes of this subsection, the term authorized generic drug

(A)

means any version of a listed drug (as such term is used in subsection (j)) that the holder of the new drug application approved under subsection (c) for that listed drug seeks to commence marketing, selling, or distributing, directly or indirectly, after receipt of a notice sent pursuant to subsection (j)(2)(B) with respect to that listed drug; and

(B)

does not include any drug to be marketed, sold, or distributed—

(i)

by an entity eligible for 180-day exclusivity with respect to such drug under subsection (j)(5)(B)(iv); or

(ii)

after expiration or forfeiture of any 180-day exclusivity with respect to such drug under such subsection (j)(5)(B)(iv).

.

(b)

Conforming amendment

Section 505(t)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(t)(3)) is amended by striking In this section and inserting In this subsection.